<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-10-09 09:12:42Health Pharmaceutical industry European Medicines Agency Supplementary protection certificate Paediatric-use marketing authorisation Orphan drug EudraCT Pharmaceutical sciences Clinical research Research |
Add to Reading List |
GRIP_Comments_PaedReg_consultation_26[removed] | There are major practical and ethical issues in relation to studying medicines in children, A new Paediatric Regulation entered into force in earlyDocID: nPad - View Document |
| Microsoft Word - ViroPharma SPRL Paediatric Regulation 26 November 2012.docxDocID: fSTd - View Document |
| Microsoft Word - Parents organizations answer to Public Consultation .docDocID: fLkE - View Document |
| ‘EXPERIENCE ACQUIRED’ AND ‘LESSONS LEARNT’ SUBMITTED FOR PUBLIC CONSULTATIONDocID: fIqA - View Document |
| Microsoft Word - ITCC_5 year SURVEY_Comments_2012_11_28.docxDocID: fHbJ - View Document |